Telix Pharmaceuticals TLX
NASDAQ TLX
$9.03 +0.04 (+0.44%)
At close: Oct 27, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Raw Materials (2023 - 2024)

Updated

Telix Pharmaceuticals (TLX) reported Raw Materials of $9.41 million for the quarter ended Dec 31, 2024, up 87.8% from $5.01 million a year earlier.

Analysis

Telix Pharmaceuticals (TLX) Raw Materials (2023 - 2024) Analysis & Trends

  • By year, Raw Materials came in at $5.01 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,206.37 Bn 1,174.95 Bn 19.71 Bn
2 Johnson & Johnson 647.04 Bn 566.90 Bn 17.30 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn
4 Merck 349.94 Bn 304.37 Bn 12.21 Bn
5 Novartis Ag 299.20 Bn 272.77 Bn -
6 Astrazeneca 263.53 Bn 237.29 Bn 12.86 Bn
7 Amgen 242.16 Bn 197.56 Bn 7.24 Bn
8 Gilead Sciences 197.42 Bn 171.53 Bn 6.22 Bn
9 Pfizer 169.85 Bn 116.80 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.06 Bn 2.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 8.95 Mn
Dec 31, 2023 5.26 Mn
API Access

Telix Pharmaceuticals Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=TLX&period=max&api_key=YOUR_API_KEY